Guest
Join us Friday, March 29th at 11:30 AM PST to learn about Tyrosine Kinase Inhibitors (TKIs), what they are and how they work, with NET expert Dr. Jennifer Chan. Dr Chan is the Vice President of the North American Neuroendocrine Tumor Society (NANETS) and the principal investigator of the CABINET trial. Hear the positive findings from that TKI study using Cabozantinib. She will discuss the latest in TKI treatments and how they may be a possible treatment option for many NET patients. A live Q&A session will follow her presentation. Have a question for the expert? A live Question & Answer session will follow the presentation. To submit your general question, go to Visit for more information.
